In another study, IL-33 stimulation of primary human CRC cells increased expression of MMP2 and MMP9, and shRNA-mediated knockdown of ST2 or inhibition of MMP2 and MMP9 reduced invasion in vitro (170). The gene discussed is IL33; the disease is colorectal carcinoma.